Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 29,932,073
- Total 13F value
- $213,117,843
- Share change
- +1,516,320
- Put/Call ratio
- 2.8%
- SEC-reported price per share
- $7.12
- Number of holders
- 73
- Value change
- +$9,111,651
- Number of buys
- 28
- Number of sells
- 40
- Shares outstanding
- 53,364,241
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
73
Top holders
10
SCPH full security history
Ownership snapshot
Full 13F holder table
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
10%
RTW INVESTMENTS, LP
6.2%
AIGH Capital Management LLC
3.8%
COWEN AND COMPANY, LLC
3.4%
BlackRock Finance, Inc.
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
10%
|
$56,651,590
5,559,528 shares
|
— | 30 Jun 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
6.2%
|
$33,605,020
3,297,843 shares
|
— | 30 Jun 2023 |
| AIGH Capital Management LLC |
13F
Company
|
3.8%
|
$20,907,893
2,051,805 shares
|
— | 30 Jun 2023 |
| COWEN AND COMPANY, LLC |
13F
Company
|
3.4%
|
$18,728,384
1,837,918 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.2%
|
$17,622,871
1,729,428 shares
|
— | 30 Jun 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
2.3%
|
$12,393,139
1,216,206 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
73
Shares
29,932,073
Rows available
73
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
81
Q3 2023 holders
73
Holder diff
-8
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|